Takeda Pharmaceutical Co Ltd (TKPHF)
26.52
0.00 (0.00%)
USD |
OTCM |
Apr 18, 16:00
Takeda Pharmaceutical Market Cap: 41.61B for April 18, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 41.61B |
| April 17, 2024 | 41.61B |
| April 16, 2024 | 41.61B |
| April 15, 2024 | 41.61B |
| April 12, 2024 | 41.61B |
| April 11, 2024 | 41.61B |
| April 10, 2024 | 41.61B |
| April 09, 2024 | 42.44B |
| April 08, 2024 | 41.72B |
| April 05, 2024 | 42.75B |
| April 04, 2024 | 41.46B |
| April 03, 2024 | 41.89B |
| April 02, 2024 | 41.89B |
| April 01, 2024 | 43.79B |
| March 28, 2024 | 44.64B |
| March 27, 2024 | 44.64B |
| March 26, 2024 | 44.64B |
| March 25, 2024 | 44.64B |
| March 22, 2024 | 45.39B |
| March 21, 2024 | 45.39B |
| March 20, 2024 | 45.39B |
| March 19, 2024 | 45.39B |
| March 18, 2024 | 45.39B |
| March 15, 2024 | 45.39B |
| March 14, 2024 | 45.39B |
| Date | Value |
|---|---|
| March 13, 2024 | 46.16B |
| March 12, 2024 | 46.16B |
| March 11, 2024 | 46.55B |
| March 08, 2024 | 46.55B |
| March 07, 2024 | 44.71B |
| March 06, 2024 | 44.71B |
| March 05, 2024 | 44.71B |
| March 04, 2024 | 44.71B |
| March 01, 2024 | 45.24B |
| February 29, 2024 | 44.92B |
| February 28, 2024 | 44.92B |
| February 27, 2024 | 44.92B |
| February 26, 2024 | 44.92B |
| February 23, 2024 | 44.92B |
| February 22, 2024 | 44.67B |
| February 21, 2024 | 45.50B |
| February 20, 2024 | 43.85B |
| February 16, 2024 | 43.85B |
| February 15, 2024 | 43.85B |
| February 14, 2024 | 44.02B |
| February 13, 2024 | 44.02B |
| February 12, 2024 | 44.09B |
| February 09, 2024 | 43.07B |
| February 08, 2024 | 43.07B |
| February 07, 2024 | 43.17B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
39.02B
Minimum
Oct 19 2022
65.47B
Maximum
Nov 19 2019
50.54B
Average
50.89B
Median
Market Cap Benchmarks
| Nxera Pharma Co Ltd | 869.42M |
| PeptiDream Inc | 1.231B |
| Stemcell Holdings Inc | 1.643M |
| Healios KK | 84.71M |
Market Cap Related Metrics
| PE Ratio | 33.03 |
| PS Ratio | 1.407 |
| Price to Book Value | 0.8703 |
| Price | 26.52 |
| Earnings Yield | 3.03% |
| Operating PE Ratio | 16.84 |
| Normalized PE Ratio | 33.03 |